Bosutinib
Overview
Bosutinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL288441).
API suppliers (4)
Suppliers of Bosutinib evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 4 suppliers.
3 of 4 hold a GMP certificate on record in the EU or UK registers
- Alembic Pharmaceuticals LimitedIndia1 active DMF GMP on record
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- ALP PHARM BEIJING CO LTD1 active DMF
- Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (8 approved US products), the latest listed US patent on Bosutinib expires 28 Aug 2034 and exclusivity 26 Mar 2031. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile
- Canonical SMILES
- CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC
- InChIKey
- UBPYILGKFZZVDX-UHFFFAOYSA-N
Do you supply Bosutinib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.